Global Multiplex Immunofluorescence (mIF) Technology Supply, Demand and Key Producers, 2026-2032
The global Multiplex Immunofluorescence (mIF) Technology market size is expected to reach $ 2389 million by 2032, rising at a market growth of 4.6% CAGR during the forecast period (2026-2032).
Multiplex Immunofluorescence (mIF) Technology is an advanced in-situ detection technology that enables simultaneous specific labeling, visualization and quantitative analysis of multiple target antigens in a single tissue section (FFPE or fresh) via fluorescent-labeled specific antibodies, integrating fluorophore spectral matching, signal amplification (e.g., TSA technology) and high-resolution imaging systems. It overcomes the limitation of traditional single immunofluorescence in target quantity, preserves the original tissue microenvironment, realizes spatial localization and co-expression analysis of multiple biomarkers, and provides high-dimensional data support for biological mechanism research and clinical detection by leveraging key fluorophore properties such as brightness, photostability and Stokes shift.
This report studies the global Multiplex Immunofluorescence (mIF) Technology demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Multiplex Immunofluorescence (mIF) Technology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Multiplex Immunofluorescence (mIF) Technology that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Multiplex Immunofluorescence (mIF) Technology total market, 2021-2032, (USD Million)
Global Multiplex Immunofluorescence (mIF) Technology total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Multiplex Immunofluorescence (mIF) Technology total market, key domestic companies, and share, (USD Million)
Global Multiplex Immunofluorescence (mIF) Technology revenue by player, revenue and market share 2021-2026, (USD Million)
Global Multiplex Immunofluorescence (mIF) Technology total market by Type, CAGR, 2021-2032, (USD Million)
Global Multiplex Immunofluorescence (mIF) Technology total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Multiplex Immunofluorescence (mIF) Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eureka Biotech, ICON plc, Discovery Life Sciences, Precision Medicine Group, Terry Technologies, MGI Tech, panovue, Biospective, iCuraDx, Yucebio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Multiplex Immunofluorescence (mIF) Technology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Multiplex Immunofluorescence (mIF) Technology Market, By Region:
1. How big is the global Multiplex Immunofluorescence (mIF) Technology market?
2. What is the demand of the global Multiplex Immunofluorescence (mIF) Technology market?
3. What is the year over year growth of the global Multiplex Immunofluorescence (mIF) Technology market?
4. What is the total value of the global Multiplex Immunofluorescence (mIF) Technology market?
5. Who are the Major Players in the global Multiplex Immunofluorescence (mIF) Technology market?
6. What are the growth factors driving the market demand?
Multiplex Immunofluorescence (mIF) Technology is an advanced in-situ detection technology that enables simultaneous specific labeling, visualization and quantitative analysis of multiple target antigens in a single tissue section (FFPE or fresh) via fluorescent-labeled specific antibodies, integrating fluorophore spectral matching, signal amplification (e.g., TSA technology) and high-resolution imaging systems. It overcomes the limitation of traditional single immunofluorescence in target quantity, preserves the original tissue microenvironment, realizes spatial localization and co-expression analysis of multiple biomarkers, and provides high-dimensional data support for biological mechanism research and clinical detection by leveraging key fluorophore properties such as brightness, photostability and Stokes shift.
This report studies the global Multiplex Immunofluorescence (mIF) Technology demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Multiplex Immunofluorescence (mIF) Technology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Multiplex Immunofluorescence (mIF) Technology that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Multiplex Immunofluorescence (mIF) Technology total market, 2021-2032, (USD Million)
Global Multiplex Immunofluorescence (mIF) Technology total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Multiplex Immunofluorescence (mIF) Technology total market, key domestic companies, and share, (USD Million)
Global Multiplex Immunofluorescence (mIF) Technology revenue by player, revenue and market share 2021-2026, (USD Million)
Global Multiplex Immunofluorescence (mIF) Technology total market by Type, CAGR, 2021-2032, (USD Million)
Global Multiplex Immunofluorescence (mIF) Technology total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Multiplex Immunofluorescence (mIF) Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eureka Biotech, ICON plc, Discovery Life Sciences, Precision Medicine Group, Terry Technologies, MGI Tech, panovue, Biospective, iCuraDx, Yucebio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Multiplex Immunofluorescence (mIF) Technology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Multiplex Immunofluorescence (mIF) Technology Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Direct Labeling mIF Technology
- TSA-based Amplification mIF Technology
- Dual-amplification mIF Technology
- Low-channel mIF Technology
- Medium-channel mIF Technology
- High-channel mIF Technology
- Tumor Immunology Research
- Clinical Pathological Diagnosis
- Immune Microenvironment Profiling
- Other
- Eureka Biotech
- ICON plc
- Discovery Life Sciences
- Precision Medicine Group
- Terry Technologies
- MGI Tech
- panovue
- Biospective
- iCuraDx
- Yucebio
- Flagship Biosciences
- Lanterne Dx (LDX)
- Crown Bioscience
1. How big is the global Multiplex Immunofluorescence (mIF) Technology market?
2. What is the demand of the global Multiplex Immunofluorescence (mIF) Technology market?
3. What is the year over year growth of the global Multiplex Immunofluorescence (mIF) Technology market?
4. What is the total value of the global Multiplex Immunofluorescence (mIF) Technology market?
5. Who are the Major Players in the global Multiplex Immunofluorescence (mIF) Technology market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 FPR2 Agonists and Antagonists Introduction
1.2 World FPR2 Agonists and Antagonists Market Size & Forecast (2021 & 2025 & 2032)
1.3 World FPR2 Agonists and Antagonists Total Market by Region (by Headquarter Location)
1.3.1 World FPR2 Agonists and Antagonists Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company FPR2 Agonists and Antagonists Revenue (2021-2032)
1.3.3 China Based Company FPR2 Agonists and Antagonists Revenue (2021-2032)
1.3.4 Europe Based Company FPR2 Agonists and Antagonists Revenue (2021-2032)
1.3.5 Japan Based Company FPR2 Agonists and Antagonists Revenue (2021-2032)
1.3.6 South Korea Based Company FPR2 Agonists and Antagonists Revenue (2021-2032)
1.3.7 ASEAN Based Company FPR2 Agonists and Antagonists Revenue (2021-2032)
1.3.8 India Based Company FPR2 Agonists and Antagonists Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 FPR2 Agonists and Antagonists Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World FPR2 Agonists and Antagonists Consumption Value (2021-2032)
2.2 World FPR2 Agonists and Antagonists Consumption Value by Region
2.2.1 World FPR2 Agonists and Antagonists Consumption Value by Region (2021-2026)
2.2.2 World FPR2 Agonists and Antagonists Consumption Value Forecast by Region (2027-2032)
2.3 United States FPR2 Agonists and Antagonists Consumption Value (2021-2032)
2.4 China FPR2 Agonists and Antagonists Consumption Value (2021-2032)
2.5 Europe FPR2 Agonists and Antagonists Consumption Value (2021-2032)
2.6 Japan FPR2 Agonists and Antagonists Consumption Value (2021-2032)
2.7 South Korea FPR2 Agonists and Antagonists Consumption Value (2021-2032)
2.8 ASEAN FPR2 Agonists and Antagonists Consumption Value (2021-2032)
2.9 India FPR2 Agonists and Antagonists Consumption Value (2021-2032)
3 WORLD FPR2 AGONISTS AND ANTAGONISTS COMPANIES COMPETITIVE ANALYSIS
3.1 World FPR2 Agonists and Antagonists Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global FPR2 Agonists and Antagonists Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for FPR2 Agonists and Antagonists in 2025
3.2.3 Global Concentration Ratios (CR8) for FPR2 Agonists and Antagonists in 2025
3.3 FPR2 Agonists and Antagonists Company Evaluation Quadrant
3.4 FPR2 Agonists and Antagonists Market: Overall Company Footprint Analysis
3.4.1 FPR2 Agonists and Antagonists Market: Region Footprint
3.4.2 FPR2 Agonists and Antagonists Market: Company Product Type Footprint
3.4.3 FPR2 Agonists and Antagonists Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: FPR2 Agonists and Antagonists Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: FPR2 Agonists and Antagonists Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: FPR2 Agonists and Antagonists Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: FPR2 Agonists and Antagonists Consumption Value Comparison
4.2.1 United States VS China: FPR2 Agonists and Antagonists Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: FPR2 Agonists and Antagonists Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based FPR2 Agonists and Antagonists Companies and Market Share, 2021-2026
4.3.1 United States Based FPR2 Agonists and Antagonists Companies, Headquarters (States, Country)
4.3.2 United States Based Companies FPR2 Agonists and Antagonists Revenue, (2021-2026)
4.4 China Based Companies FPR2 Agonists and Antagonists Revenue and Market Share, 2021-2026
4.4.1 China Based FPR2 Agonists and Antagonists Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies FPR2 Agonists and Antagonists Revenue, (2021-2026)
4.5 Rest of World Based FPR2 Agonists and Antagonists Companies and Market Share, 2021-2026
4.5.1 Rest of World Based FPR2 Agonists and Antagonists Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies FPR2 Agonists and Antagonists Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World FPR2 Agonists and Antagonists Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Agonists
5.2.2 Antagonists
5.3 Market Segment by Type
5.3.1 World FPR2 Agonists and Antagonists Market Size by Type (2021-2026)
5.3.2 World FPR2 Agonists and Antagonists Market Size by Type (2027-2032)
5.3.3 World FPR2 Agonists and Antagonists Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY MOLECULAR TYPE
6.1 World FPR2 Agonists and Antagonists Market Size Overview by Molecular Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Molecular Type
6.2.1 Lipid Mediators
6.2.2 Peptides
6.2.3 Proteins
6.2.4 Small Molecule Synthetic Compounds
6.3 Market Segment by Molecular Type
6.3.1 World FPR2 Agonists and Antagonists Market Size by Molecular Type (2021-2026)
6.3.2 World FPR2 Agonists and Antagonists Market Size by Molecular Type (2027-2032)
6.3.3 World FPR2 Agonists and Antagonists Market Size Market Share by Molecular Type (2027-2032)
7 MARKET ANALYSIS BY SOURCE
7.1 World FPR2 Agonists and Antagonists Market Size Overview by Source: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Source
7.2.1 Endogenous
7.2.2 Exogenous
7.3 Market Segment by Source
7.3.1 World FPR2 Agonists and Antagonists Market Size by Source (2021-2026)
7.3.2 World FPR2 Agonists and Antagonists Market Size by Source (2027-2032)
7.3.3 World FPR2 Agonists and Antagonists Market Size Market Share by Source (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World FPR2 Agonists and Antagonists Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical Company
8.2.2 Universities and Research Institutes
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World FPR2 Agonists and Antagonists Market Size by Application (2021-2026)
8.3.2 World FPR2 Agonists and Antagonists Market Size by Application (2027-2032)
8.3.3 World FPR2 Agonists and Antagonists Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Bio-Techne
9.1.1 Bio-Techne Details
9.1.2 Bio-Techne Major Business
9.1.3 Bio-Techne FPR2 Agonists and Antagonists Product and Services
9.1.4 Bio-Techne FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Bio-Techne Recent Developments/Updates
9.1.6 Bio-Techne Competitive Strengths & Weaknesses
9.2 Abcam
9.2.1 Abcam Details
9.2.2 Abcam Major Business
9.2.3 Abcam FPR2 Agonists and Antagonists Product and Services
9.2.4 Abcam FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Abcam Recent Developments/Updates
9.2.6 Abcam Competitive Strengths & Weaknesses
9.3 Enzo Life Sciences
9.3.1 Enzo Life Sciences Details
9.3.2 Enzo Life Sciences Major Business
9.3.3 Enzo Life Sciences FPR2 Agonists and Antagonists Product and Services
9.3.4 Enzo Life Sciences FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Enzo Life Sciences Recent Developments/Updates
9.3.6 Enzo Life Sciences Competitive Strengths & Weaknesses
9.4 MedChemExpress
9.4.1 MedChemExpress Details
9.4.2 MedChemExpress Major Business
9.4.3 MedChemExpress FPR2 Agonists and Antagonists Product and Services
9.4.4 MedChemExpress FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 MedChemExpress Recent Developments/Updates
9.4.6 MedChemExpress Competitive Strengths & Weaknesses
9.5 Anaspec
9.5.1 Anaspec Details
9.5.2 Anaspec Major Business
9.5.3 Anaspec FPR2 Agonists and Antagonists Product and Services
9.5.4 Anaspec FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Anaspec Recent Developments/Updates
9.5.6 Anaspec Competitive Strengths & Weaknesses
9.6 Merck
9.6.1 Merck Details
9.6.2 Merck Major Business
9.6.3 Merck FPR2 Agonists and Antagonists Product and Services
9.6.4 Merck FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Merck Recent Developments/Updates
9.6.6 Merck Competitive Strengths & Weaknesses
9.7 Discoverx
9.7.1 Discoverx Details
9.7.2 Discoverx Major Business
9.7.3 Discoverx FPR2 Agonists and Antagonists Product and Services
9.7.4 Discoverx FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Discoverx Recent Developments/Updates
9.7.6 Discoverx Competitive Strengths & Weaknesses
9.8 BioGems
9.8.1 BioGems Details
9.8.2 BioGems Major Business
9.8.3 BioGems FPR2 Agonists and Antagonists Product and Services
9.8.4 BioGems FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 BioGems Recent Developments/Updates
9.8.6 BioGems Competitive Strengths & Weaknesses
9.9 GenScript Company
9.9.1 GenScript Company Details
9.9.2 GenScript Company Major Business
9.9.3 GenScript Company FPR2 Agonists and Antagonists Product and Services
9.9.4 GenScript Company FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 GenScript Company Recent Developments/Updates
9.9.6 GenScript Company Competitive Strengths & Weaknesses
9.10 Alomone Labs
9.10.1 Alomone Labs Details
9.10.2 Alomone Labs Major Business
9.10.3 Alomone Labs FPR2 Agonists and Antagonists Product and Services
9.10.4 Alomone Labs FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Alomone Labs Recent Developments/Updates
9.10.6 Alomone Labs Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 FPR2 Agonists and Antagonists Industry Chain
10.2 FPR2 Agonists and Antagonists Upstream Analysis
10.3 FPR2 Agonists and Antagonists Midstream Analysis
10.4 FPR2 Agonists and Antagonists Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 FPR2 Agonists and Antagonists Introduction
1.2 World FPR2 Agonists and Antagonists Market Size & Forecast (2021 & 2025 & 2032)
1.3 World FPR2 Agonists and Antagonists Total Market by Region (by Headquarter Location)
1.3.1 World FPR2 Agonists and Antagonists Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company FPR2 Agonists and Antagonists Revenue (2021-2032)
1.3.3 China Based Company FPR2 Agonists and Antagonists Revenue (2021-2032)
1.3.4 Europe Based Company FPR2 Agonists and Antagonists Revenue (2021-2032)
1.3.5 Japan Based Company FPR2 Agonists and Antagonists Revenue (2021-2032)
1.3.6 South Korea Based Company FPR2 Agonists and Antagonists Revenue (2021-2032)
1.3.7 ASEAN Based Company FPR2 Agonists and Antagonists Revenue (2021-2032)
1.3.8 India Based Company FPR2 Agonists and Antagonists Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 FPR2 Agonists and Antagonists Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World FPR2 Agonists and Antagonists Consumption Value (2021-2032)
2.2 World FPR2 Agonists and Antagonists Consumption Value by Region
2.2.1 World FPR2 Agonists and Antagonists Consumption Value by Region (2021-2026)
2.2.2 World FPR2 Agonists and Antagonists Consumption Value Forecast by Region (2027-2032)
2.3 United States FPR2 Agonists and Antagonists Consumption Value (2021-2032)
2.4 China FPR2 Agonists and Antagonists Consumption Value (2021-2032)
2.5 Europe FPR2 Agonists and Antagonists Consumption Value (2021-2032)
2.6 Japan FPR2 Agonists and Antagonists Consumption Value (2021-2032)
2.7 South Korea FPR2 Agonists and Antagonists Consumption Value (2021-2032)
2.8 ASEAN FPR2 Agonists and Antagonists Consumption Value (2021-2032)
2.9 India FPR2 Agonists and Antagonists Consumption Value (2021-2032)
3 WORLD FPR2 AGONISTS AND ANTAGONISTS COMPANIES COMPETITIVE ANALYSIS
3.1 World FPR2 Agonists and Antagonists Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global FPR2 Agonists and Antagonists Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for FPR2 Agonists and Antagonists in 2025
3.2.3 Global Concentration Ratios (CR8) for FPR2 Agonists and Antagonists in 2025
3.3 FPR2 Agonists and Antagonists Company Evaluation Quadrant
3.4 FPR2 Agonists and Antagonists Market: Overall Company Footprint Analysis
3.4.1 FPR2 Agonists and Antagonists Market: Region Footprint
3.4.2 FPR2 Agonists and Antagonists Market: Company Product Type Footprint
3.4.3 FPR2 Agonists and Antagonists Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: FPR2 Agonists and Antagonists Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: FPR2 Agonists and Antagonists Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: FPR2 Agonists and Antagonists Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: FPR2 Agonists and Antagonists Consumption Value Comparison
4.2.1 United States VS China: FPR2 Agonists and Antagonists Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: FPR2 Agonists and Antagonists Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based FPR2 Agonists and Antagonists Companies and Market Share, 2021-2026
4.3.1 United States Based FPR2 Agonists and Antagonists Companies, Headquarters (States, Country)
4.3.2 United States Based Companies FPR2 Agonists and Antagonists Revenue, (2021-2026)
4.4 China Based Companies FPR2 Agonists and Antagonists Revenue and Market Share, 2021-2026
4.4.1 China Based FPR2 Agonists and Antagonists Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies FPR2 Agonists and Antagonists Revenue, (2021-2026)
4.5 Rest of World Based FPR2 Agonists and Antagonists Companies and Market Share, 2021-2026
4.5.1 Rest of World Based FPR2 Agonists and Antagonists Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies FPR2 Agonists and Antagonists Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World FPR2 Agonists and Antagonists Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Agonists
5.2.2 Antagonists
5.3 Market Segment by Type
5.3.1 World FPR2 Agonists and Antagonists Market Size by Type (2021-2026)
5.3.2 World FPR2 Agonists and Antagonists Market Size by Type (2027-2032)
5.3.3 World FPR2 Agonists and Antagonists Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY MOLECULAR TYPE
6.1 World FPR2 Agonists and Antagonists Market Size Overview by Molecular Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Molecular Type
6.2.1 Lipid Mediators
6.2.2 Peptides
6.2.3 Proteins
6.2.4 Small Molecule Synthetic Compounds
6.3 Market Segment by Molecular Type
6.3.1 World FPR2 Agonists and Antagonists Market Size by Molecular Type (2021-2026)
6.3.2 World FPR2 Agonists and Antagonists Market Size by Molecular Type (2027-2032)
6.3.3 World FPR2 Agonists and Antagonists Market Size Market Share by Molecular Type (2027-2032)
7 MARKET ANALYSIS BY SOURCE
7.1 World FPR2 Agonists and Antagonists Market Size Overview by Source: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Source
7.2.1 Endogenous
7.2.2 Exogenous
7.3 Market Segment by Source
7.3.1 World FPR2 Agonists and Antagonists Market Size by Source (2021-2026)
7.3.2 World FPR2 Agonists and Antagonists Market Size by Source (2027-2032)
7.3.3 World FPR2 Agonists and Antagonists Market Size Market Share by Source (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World FPR2 Agonists and Antagonists Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical Company
8.2.2 Universities and Research Institutes
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World FPR2 Agonists and Antagonists Market Size by Application (2021-2026)
8.3.2 World FPR2 Agonists and Antagonists Market Size by Application (2027-2032)
8.3.3 World FPR2 Agonists and Antagonists Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Bio-Techne
9.1.1 Bio-Techne Details
9.1.2 Bio-Techne Major Business
9.1.3 Bio-Techne FPR2 Agonists and Antagonists Product and Services
9.1.4 Bio-Techne FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Bio-Techne Recent Developments/Updates
9.1.6 Bio-Techne Competitive Strengths & Weaknesses
9.2 Abcam
9.2.1 Abcam Details
9.2.2 Abcam Major Business
9.2.3 Abcam FPR2 Agonists and Antagonists Product and Services
9.2.4 Abcam FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Abcam Recent Developments/Updates
9.2.6 Abcam Competitive Strengths & Weaknesses
9.3 Enzo Life Sciences
9.3.1 Enzo Life Sciences Details
9.3.2 Enzo Life Sciences Major Business
9.3.3 Enzo Life Sciences FPR2 Agonists and Antagonists Product and Services
9.3.4 Enzo Life Sciences FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Enzo Life Sciences Recent Developments/Updates
9.3.6 Enzo Life Sciences Competitive Strengths & Weaknesses
9.4 MedChemExpress
9.4.1 MedChemExpress Details
9.4.2 MedChemExpress Major Business
9.4.3 MedChemExpress FPR2 Agonists and Antagonists Product and Services
9.4.4 MedChemExpress FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 MedChemExpress Recent Developments/Updates
9.4.6 MedChemExpress Competitive Strengths & Weaknesses
9.5 Anaspec
9.5.1 Anaspec Details
9.5.2 Anaspec Major Business
9.5.3 Anaspec FPR2 Agonists and Antagonists Product and Services
9.5.4 Anaspec FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Anaspec Recent Developments/Updates
9.5.6 Anaspec Competitive Strengths & Weaknesses
9.6 Merck
9.6.1 Merck Details
9.6.2 Merck Major Business
9.6.3 Merck FPR2 Agonists and Antagonists Product and Services
9.6.4 Merck FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Merck Recent Developments/Updates
9.6.6 Merck Competitive Strengths & Weaknesses
9.7 Discoverx
9.7.1 Discoverx Details
9.7.2 Discoverx Major Business
9.7.3 Discoverx FPR2 Agonists and Antagonists Product and Services
9.7.4 Discoverx FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Discoverx Recent Developments/Updates
9.7.6 Discoverx Competitive Strengths & Weaknesses
9.8 BioGems
9.8.1 BioGems Details
9.8.2 BioGems Major Business
9.8.3 BioGems FPR2 Agonists and Antagonists Product and Services
9.8.4 BioGems FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 BioGems Recent Developments/Updates
9.8.6 BioGems Competitive Strengths & Weaknesses
9.9 GenScript Company
9.9.1 GenScript Company Details
9.9.2 GenScript Company Major Business
9.9.3 GenScript Company FPR2 Agonists and Antagonists Product and Services
9.9.4 GenScript Company FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 GenScript Company Recent Developments/Updates
9.9.6 GenScript Company Competitive Strengths & Weaknesses
9.10 Alomone Labs
9.10.1 Alomone Labs Details
9.10.2 Alomone Labs Major Business
9.10.3 Alomone Labs FPR2 Agonists and Antagonists Product and Services
9.10.4 Alomone Labs FPR2 Agonists and Antagonists Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Alomone Labs Recent Developments/Updates
9.10.6 Alomone Labs Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 FPR2 Agonists and Antagonists Industry Chain
10.2 FPR2 Agonists and Antagonists Upstream Analysis
10.3 FPR2 Agonists and Antagonists Midstream Analysis
10.4 FPR2 Agonists and Antagonists Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Multiplex Immunofluorescence (mIF) Technology Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Multiplex Immunofluorescence (mIF) Technology Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Multiplex Immunofluorescence (mIF) Technology Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Multiplex Immunofluorescence (mIF) Technology Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Multiplex Immunofluorescence (mIF) Technology Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Multiplex Immunofluorescence (mIF) Technology Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Multiplex Immunofluorescence (mIF) Technology Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Multiplex Immunofluorescence (mIF) Technology Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Multiplex Immunofluorescence (mIF) Technology Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Multiplex Immunofluorescence (mIF) Technology Players in 2025
Table 12. World Multiplex Immunofluorescence (mIF) Technology Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Multiplex Immunofluorescence (mIF) Technology Company Evaluation Quadrant
Table 14. Head Office of Key Multiplex Immunofluorescence (mIF) Technology Players
Table 15. Multiplex Immunofluorescence (mIF) Technology Market: Company Product Type Footprint
Table 16. Multiplex Immunofluorescence (mIF) Technology Market: Company Product Application Footprint
Table 17. Multiplex Immunofluorescence (mIF) Technology Mergers & Acquisitions Activity
Table 18. United States VS China Multiplex Immunofluorescence (mIF) Technology Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Multiplex Immunofluorescence (mIF) Technology Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Multiplex Immunofluorescence (mIF) Technology Companies, Headquarters (States, Country)
Table 21. United States Based Companies Multiplex Immunofluorescence (mIF) Technology Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Multiplex Immunofluorescence (mIF) Technology Revenue Market Share (2021-2026)
Table 23. China Based Multiplex Immunofluorescence (mIF) Technology Companies, Headquarters (Province, Country)
Table 24. China Based Companies Multiplex Immunofluorescence (mIF) Technology Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Multiplex Immunofluorescence (mIF) Technology Revenue Market Share (2021-2026)
Table 26. Rest of World Based Multiplex Immunofluorescence (mIF) Technology Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Multiplex Immunofluorescence (mIF) Technology Revenue Market Share (2021-2026)
Table 29. World Multiplex Immunofluorescence (mIF) Technology Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Multiplex Immunofluorescence (mIF) Technology Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Multiplex Immunofluorescence (mIF) Technology Market Size by Type (2027-2032) & (USD Million)
Table 32. World Multiplex Immunofluorescence (mIF) Technology Market Size by Fluorescence Channel Count, (USD Million), 2021 & 2025 & 2032
Table 33. World Multiplex Immunofluorescence (mIF) Technology Market Size Value by Fluorescence Channel Count (2021-2026) & (USD Million)
Table 34. World Multiplex Immunofluorescence (mIF) Technology Market Size by Fluorescence Channel Count (2027-2032) & (USD Million)
Table 35. World Multiplex Immunofluorescence (mIF) Technology Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Multiplex Immunofluorescence (mIF) Technology Market Size by Application (2021-2026) & (USD Million)
Table 37. World Multiplex Immunofluorescence (mIF) Technology Market Size by Application (2027-2032) & (USD Million)
Table 38. Eureka Biotech Basic Information, Manufacturing Base and Competitors
Table 39. Eureka Biotech Major Business
Table 40. Eureka Biotech Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 41. Eureka Biotech Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Eureka Biotech Recent Developments/Updates
Table 43. Eureka Biotech Competitive Strengths & Weaknesses
Table 44. ICON plc Basic Information, Manufacturing Base and Competitors
Table 45. ICON plc Major Business
Table 46. ICON plc Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 47. ICON plc Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. ICON plc Recent Developments/Updates
Table 49. ICON plc Competitive Strengths & Weaknesses
Table 50. Discovery Life Sciences Basic Information, Manufacturing Base and Competitors
Table 51. Discovery Life Sciences Major Business
Table 52. Discovery Life Sciences Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 53. Discovery Life Sciences Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Discovery Life Sciences Recent Developments/Updates
Table 55. Discovery Life Sciences Competitive Strengths & Weaknesses
Table 56. Precision Medicine Group Basic Information, Manufacturing Base and Competitors
Table 57. Precision Medicine Group Major Business
Table 58. Precision Medicine Group Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 59. Precision Medicine Group Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Precision Medicine Group Recent Developments/Updates
Table 61. Precision Medicine Group Competitive Strengths & Weaknesses
Table 62. Terry Technologies Basic Information, Manufacturing Base and Competitors
Table 63. Terry Technologies Major Business
Table 64. Terry Technologies Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 65. Terry Technologies Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Terry Technologies Recent Developments/Updates
Table 67. Terry Technologies Competitive Strengths & Weaknesses
Table 68. MGI Tech Basic Information, Manufacturing Base and Competitors
Table 69. MGI Tech Major Business
Table 70. MGI Tech Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 71. MGI Tech Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. MGI Tech Recent Developments/Updates
Table 73. MGI Tech Competitive Strengths & Weaknesses
Table 74. panovue Basic Information, Manufacturing Base and Competitors
Table 75. panovue Major Business
Table 76. panovue Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 77. panovue Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. panovue Recent Developments/Updates
Table 79. panovue Competitive Strengths & Weaknesses
Table 80. Biospective Basic Information, Manufacturing Base and Competitors
Table 81. Biospective Major Business
Table 82. Biospective Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 83. Biospective Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Biospective Recent Developments/Updates
Table 85. Biospective Competitive Strengths & Weaknesses
Table 86. iCuraDx Basic Information, Manufacturing Base and Competitors
Table 87. iCuraDx Major Business
Table 88. iCuraDx Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 89. iCuraDx Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. iCuraDx Recent Developments/Updates
Table 91. iCuraDx Competitive Strengths & Weaknesses
Table 92. Yucebio Basic Information, Manufacturing Base and Competitors
Table 93. Yucebio Major Business
Table 94. Yucebio Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 95. Yucebio Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Yucebio Recent Developments/Updates
Table 97. Yucebio Competitive Strengths & Weaknesses
Table 98. Flagship Biosciences Basic Information, Manufacturing Base and Competitors
Table 99. Flagship Biosciences Major Business
Table 100. Flagship Biosciences Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 101. Flagship Biosciences Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Flagship Biosciences Recent Developments/Updates
Table 103. Flagship Biosciences Competitive Strengths & Weaknesses
Table 104. Lanterne Dx (LDX) Basic Information, Manufacturing Base and Competitors
Table 105. Lanterne Dx (LDX) Major Business
Table 106. Lanterne Dx (LDX) Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 107. Lanterne Dx (LDX) Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Lanterne Dx (LDX) Recent Developments/Updates
Table 109. Lanterne Dx (LDX) Competitive Strengths & Weaknesses
Table 110. Crown Bioscience Basic Information, Manufacturing Base and Competitors
Table 111. Crown Bioscience Major Business
Table 112. Crown Bioscience Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 113. Crown Bioscience Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Crown Bioscience Recent Developments/Updates
Table 115. Crown Bioscience Competitive Strengths & Weaknesses
Table 116. Global Key Players of Multiplex Immunofluorescence (mIF) Technology Upstream (Raw Materials)
Table 117. Global Multiplex Immunofluorescence (mIF) Technology Typical Customers
Table 1. World Multiplex Immunofluorescence (mIF) Technology Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Multiplex Immunofluorescence (mIF) Technology Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Multiplex Immunofluorescence (mIF) Technology Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Multiplex Immunofluorescence (mIF) Technology Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Multiplex Immunofluorescence (mIF) Technology Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Multiplex Immunofluorescence (mIF) Technology Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Multiplex Immunofluorescence (mIF) Technology Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Multiplex Immunofluorescence (mIF) Technology Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Multiplex Immunofluorescence (mIF) Technology Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Multiplex Immunofluorescence (mIF) Technology Players in 2025
Table 12. World Multiplex Immunofluorescence (mIF) Technology Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Multiplex Immunofluorescence (mIF) Technology Company Evaluation Quadrant
Table 14. Head Office of Key Multiplex Immunofluorescence (mIF) Technology Players
Table 15. Multiplex Immunofluorescence (mIF) Technology Market: Company Product Type Footprint
Table 16. Multiplex Immunofluorescence (mIF) Technology Market: Company Product Application Footprint
Table 17. Multiplex Immunofluorescence (mIF) Technology Mergers & Acquisitions Activity
Table 18. United States VS China Multiplex Immunofluorescence (mIF) Technology Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Multiplex Immunofluorescence (mIF) Technology Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Multiplex Immunofluorescence (mIF) Technology Companies, Headquarters (States, Country)
Table 21. United States Based Companies Multiplex Immunofluorescence (mIF) Technology Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Multiplex Immunofluorescence (mIF) Technology Revenue Market Share (2021-2026)
Table 23. China Based Multiplex Immunofluorescence (mIF) Technology Companies, Headquarters (Province, Country)
Table 24. China Based Companies Multiplex Immunofluorescence (mIF) Technology Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Multiplex Immunofluorescence (mIF) Technology Revenue Market Share (2021-2026)
Table 26. Rest of World Based Multiplex Immunofluorescence (mIF) Technology Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Multiplex Immunofluorescence (mIF) Technology Revenue Market Share (2021-2026)
Table 29. World Multiplex Immunofluorescence (mIF) Technology Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Multiplex Immunofluorescence (mIF) Technology Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Multiplex Immunofluorescence (mIF) Technology Market Size by Type (2027-2032) & (USD Million)
Table 32. World Multiplex Immunofluorescence (mIF) Technology Market Size by Fluorescence Channel Count, (USD Million), 2021 & 2025 & 2032
Table 33. World Multiplex Immunofluorescence (mIF) Technology Market Size Value by Fluorescence Channel Count (2021-2026) & (USD Million)
Table 34. World Multiplex Immunofluorescence (mIF) Technology Market Size by Fluorescence Channel Count (2027-2032) & (USD Million)
Table 35. World Multiplex Immunofluorescence (mIF) Technology Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Multiplex Immunofluorescence (mIF) Technology Market Size by Application (2021-2026) & (USD Million)
Table 37. World Multiplex Immunofluorescence (mIF) Technology Market Size by Application (2027-2032) & (USD Million)
Table 38. Eureka Biotech Basic Information, Manufacturing Base and Competitors
Table 39. Eureka Biotech Major Business
Table 40. Eureka Biotech Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 41. Eureka Biotech Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Eureka Biotech Recent Developments/Updates
Table 43. Eureka Biotech Competitive Strengths & Weaknesses
Table 44. ICON plc Basic Information, Manufacturing Base and Competitors
Table 45. ICON plc Major Business
Table 46. ICON plc Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 47. ICON plc Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. ICON plc Recent Developments/Updates
Table 49. ICON plc Competitive Strengths & Weaknesses
Table 50. Discovery Life Sciences Basic Information, Manufacturing Base and Competitors
Table 51. Discovery Life Sciences Major Business
Table 52. Discovery Life Sciences Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 53. Discovery Life Sciences Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Discovery Life Sciences Recent Developments/Updates
Table 55. Discovery Life Sciences Competitive Strengths & Weaknesses
Table 56. Precision Medicine Group Basic Information, Manufacturing Base and Competitors
Table 57. Precision Medicine Group Major Business
Table 58. Precision Medicine Group Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 59. Precision Medicine Group Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. Precision Medicine Group Recent Developments/Updates
Table 61. Precision Medicine Group Competitive Strengths & Weaknesses
Table 62. Terry Technologies Basic Information, Manufacturing Base and Competitors
Table 63. Terry Technologies Major Business
Table 64. Terry Technologies Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 65. Terry Technologies Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Terry Technologies Recent Developments/Updates
Table 67. Terry Technologies Competitive Strengths & Weaknesses
Table 68. MGI Tech Basic Information, Manufacturing Base and Competitors
Table 69. MGI Tech Major Business
Table 70. MGI Tech Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 71. MGI Tech Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. MGI Tech Recent Developments/Updates
Table 73. MGI Tech Competitive Strengths & Weaknesses
Table 74. panovue Basic Information, Manufacturing Base and Competitors
Table 75. panovue Major Business
Table 76. panovue Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 77. panovue Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. panovue Recent Developments/Updates
Table 79. panovue Competitive Strengths & Weaknesses
Table 80. Biospective Basic Information, Manufacturing Base and Competitors
Table 81. Biospective Major Business
Table 82. Biospective Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 83. Biospective Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Biospective Recent Developments/Updates
Table 85. Biospective Competitive Strengths & Weaknesses
Table 86. iCuraDx Basic Information, Manufacturing Base and Competitors
Table 87. iCuraDx Major Business
Table 88. iCuraDx Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 89. iCuraDx Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. iCuraDx Recent Developments/Updates
Table 91. iCuraDx Competitive Strengths & Weaknesses
Table 92. Yucebio Basic Information, Manufacturing Base and Competitors
Table 93. Yucebio Major Business
Table 94. Yucebio Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 95. Yucebio Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Yucebio Recent Developments/Updates
Table 97. Yucebio Competitive Strengths & Weaknesses
Table 98. Flagship Biosciences Basic Information, Manufacturing Base and Competitors
Table 99. Flagship Biosciences Major Business
Table 100. Flagship Biosciences Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 101. Flagship Biosciences Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Flagship Biosciences Recent Developments/Updates
Table 103. Flagship Biosciences Competitive Strengths & Weaknesses
Table 104. Lanterne Dx (LDX) Basic Information, Manufacturing Base and Competitors
Table 105. Lanterne Dx (LDX) Major Business
Table 106. Lanterne Dx (LDX) Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 107. Lanterne Dx (LDX) Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Lanterne Dx (LDX) Recent Developments/Updates
Table 109. Lanterne Dx (LDX) Competitive Strengths & Weaknesses
Table 110. Crown Bioscience Basic Information, Manufacturing Base and Competitors
Table 111. Crown Bioscience Major Business
Table 112. Crown Bioscience Multiplex Immunofluorescence (mIF) Technology Product and Services
Table 113. Crown Bioscience Multiplex Immunofluorescence (mIF) Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Crown Bioscience Recent Developments/Updates
Table 115. Crown Bioscience Competitive Strengths & Weaknesses
Table 116. Global Key Players of Multiplex Immunofluorescence (mIF) Technology Upstream (Raw Materials)
Table 117. Global Multiplex Immunofluorescence (mIF) Technology Typical Customers
LIST OF FIGURES
Figure 1. Multiplex Immunofluorescence (mIF) Technology Picture
Figure 2. World Multiplex Immunofluorescence (mIF) Technology Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Multiplex Immunofluorescence (mIF) Technology Total Revenue (2021-2032) & (USD Million)
Figure 4. World Multiplex Immunofluorescence (mIF) Technology Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Multiplex Immunofluorescence (mIF) Technology Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2032) & (USD Million)
Figure 13. Multiplex Immunofluorescence (mIF) Technology Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 16. World Multiplex Immunofluorescence (mIF) Technology Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 18. China Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 23. India Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Multiplex Immunofluorescence (mIF) Technology by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Multiplex Immunofluorescence (mIF) Technology Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Multiplex Immunofluorescence (mIF) Technology Markets in 2025
Figure 27. United States VS China: Multiplex Immunofluorescence (mIF) Technology Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Multiplex Immunofluorescence (mIF) Technology Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Multiplex Immunofluorescence (mIF) Technology Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Multiplex Immunofluorescence (mIF) Technology Market Size Market Share by Type in 2025
Figure 31. Direct Labeling mIF Technology
Figure 32. TSA-based Amplification mIF Technology
Figure 33. Dual-amplification mIF Technology
Figure 34. World Multiplex Immunofluorescence (mIF) Technology Market Size Market Share by Type (2021-2032)
Figure 35. World Multiplex Immunofluorescence (mIF) Technology Market Size by Fluorescence Channel Count, (USD Million), 2021 & 2025 & 2032
Figure 36. World Multiplex Immunofluorescence (mIF) Technology Market Size Market Share by Fluorescence Channel Count in 2025
Figure 37. Low-channel mIF Technology
Figure 38. Medium-channel mIF Technology
Figure 39. High-channel mIF Technology
Figure 40. World Multiplex Immunofluorescence (mIF) Technology Market Size Market Share by Fluorescence Channel Count (2021-2032)
Figure 41. World Multiplex Immunofluorescence (mIF) Technology Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 42. World Multiplex Immunofluorescence (mIF) Technology Market Size Market Share by Application in 2025
Figure 43. Tumor Immunology Research
Figure 44. Clinical Pathological Diagnosis
Figure 45. Immune Microenvironment Profiling
Figure 46. Other
Figure 47. World Multiplex Immunofluorescence (mIF) Technology Market Size Market Share by Application (2021-2032)
Figure 48. Multiplex Immunofluorescence (mIF) Technology Industrial Chain
Figure 49. Methodology
Figure 50. Research Process and Data Source
Figure 1. Multiplex Immunofluorescence (mIF) Technology Picture
Figure 2. World Multiplex Immunofluorescence (mIF) Technology Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Multiplex Immunofluorescence (mIF) Technology Total Revenue (2021-2032) & (USD Million)
Figure 4. World Multiplex Immunofluorescence (mIF) Technology Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Multiplex Immunofluorescence (mIF) Technology Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Multiplex Immunofluorescence (mIF) Technology Revenue (2021-2032) & (USD Million)
Figure 13. Multiplex Immunofluorescence (mIF) Technology Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 16. World Multiplex Immunofluorescence (mIF) Technology Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 18. China Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 23. India Multiplex Immunofluorescence (mIF) Technology Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Multiplex Immunofluorescence (mIF) Technology by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Multiplex Immunofluorescence (mIF) Technology Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Multiplex Immunofluorescence (mIF) Technology Markets in 2025
Figure 27. United States VS China: Multiplex Immunofluorescence (mIF) Technology Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Multiplex Immunofluorescence (mIF) Technology Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Multiplex Immunofluorescence (mIF) Technology Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Multiplex Immunofluorescence (mIF) Technology Market Size Market Share by Type in 2025
Figure 31. Direct Labeling mIF Technology
Figure 32. TSA-based Amplification mIF Technology
Figure 33. Dual-amplification mIF Technology
Figure 34. World Multiplex Immunofluorescence (mIF) Technology Market Size Market Share by Type (2021-2032)
Figure 35. World Multiplex Immunofluorescence (mIF) Technology Market Size by Fluorescence Channel Count, (USD Million), 2021 & 2025 & 2032
Figure 36. World Multiplex Immunofluorescence (mIF) Technology Market Size Market Share by Fluorescence Channel Count in 2025
Figure 37. Low-channel mIF Technology
Figure 38. Medium-channel mIF Technology
Figure 39. High-channel mIF Technology
Figure 40. World Multiplex Immunofluorescence (mIF) Technology Market Size Market Share by Fluorescence Channel Count (2021-2032)
Figure 41. World Multiplex Immunofluorescence (mIF) Technology Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 42. World Multiplex Immunofluorescence (mIF) Technology Market Size Market Share by Application in 2025
Figure 43. Tumor Immunology Research
Figure 44. Clinical Pathological Diagnosis
Figure 45. Immune Microenvironment Profiling
Figure 46. Other
Figure 47. World Multiplex Immunofluorescence (mIF) Technology Market Size Market Share by Application (2021-2032)
Figure 48. Multiplex Immunofluorescence (mIF) Technology Industrial Chain
Figure 49. Methodology
Figure 50. Research Process and Data Source
